How Often to Inject CJC-1295 DAC

How often to inject CJC-1295 DAC is usually once weekly thanks to its long half-life. Learn typical dosing schedules, timing, injection tips, and safety.

ARTICLE OVERVIEW

How often to inject CJC-1295 DAC is usually once weekly thanks to its long half-life. Learn typical dosing schedules, timing, injection tips, and safety.

Most CJC-1295 DAC protocols call for one injection per week, usually 1 to 2 mg. This long-acting growth hormone-releasing hormone (GHRH) analog stays active for about 6 to 8 days because its Drug Affinity Complex (DAC) binds to albumin in the bloodstream. Some researchers split the weekly total into two smaller injections given every three to four days, but once-weekly dosing is the standard.

Why CJC-1295 DAC Is Usually Injected Once a Week

CJC-1295 DAC is a modified form of GHRH with a molecular extension that attaches to albumin after injection. That albumin binding protects the peptide from rapid breakdown and extends its half-life to roughly 6 to 8 days. Because the active peptide remains in circulation for nearly a week, frequent injections are unnecessary and can lead to overlapping doses.

In contrast, natural GHRH and short-acting analogs last only minutes. The DAC technology is what makes weekly or biweekly dosing possible. Researchers typically aim for stable growth hormone and IGF-1 elevations rather than sharp spikes, which is another reason less frequent administration is preferred.

Typical CJC-1295 DAC Dosing Schedules

There is no universally accepted dosing schedule because CJC-1295 DAC is not approved for human use. However, common research protocols fall into three general patterns.

ProtocolWeekly DoseInjection FrequencyNotes
Standard2 mgOnce every 7 daysMost common in research settings
Split dose2 mg1 mg every 3–4 daysMay reduce peak effects
Low dose1 mgOnce every 7 daysUsed when starting out

For researchers asking how to dose cjc 1295 with dac, the most cited approach is 2 mg once weekly. Some users begin with 1 mg weekly to assess tolerance before moving to the standard amount. The split-dose method is sometimes used to smooth out side effects, though it is less common.

CJC-1295 DAC vs. CJC-1295 Without DAC: How Frequency Changes

The name CJC-1295 is often used for two different peptides. CJC-1295 DAC contains the Drug Affinity Complex. CJC-1295 without DAC (also called mod GRF 1-29) does not. Their dosing frequencies are very different.

VersionHalf-LifeTypical Injection FrequencyTypical Dose per Injection
CJC-1295 DAC6–8 daysOnce weekly1–2 mg
CJC-1295 without DAC30 minutes1–3 times daily100 mcg

Because the non-DAC version clears so quickly, it is often stacked with ipamorelin and injected multiple times per day. If you are researching how often do you inject cjc-1295 ipamorelin, the answer usually falls between one and three daily injections, depending on the protocol. Many guides on how to inject cjc 1295 ipamorelin recommend subcutaneous shots before meals or before bed. CJC-1295 DAC, by contrast, is not typically combined with ipamorelin on a daily basis because its long half-life already provides continuous GHRH stimulation.

How to Reconstitute and Inject CJC-1295 DAC

CJC-1295 DAC is sold as a lyophilized powder and must be mixed with bacteriostatic water before use. The process is straightforward, but sterility matters.

  1. Clean the rubber stoppers of the peptide vial and the bacteriostatic water vial with alcohol swabs.
  2. Draw the desired amount of bacteriostatic water into a syringe.
  3. Insert the needle into the peptide vial at an angle and let the water run down the glass wall instead of directly onto the powder.
  4. Gently swirl the vial until the powder dissolves completely. Do not shake it.
  5. Store the reconstituted peptide in the refrigerator, ideally at 36–46°F (2–8°C).

If you are unsure how to reconstitute cjc-1295 dac, follow the steps above and use a peptide calculator to confirm the concentration. A common mixture is 2 mg of peptide with 1–2 mL of bacteriostatic water.

For injection, most researchers use a 29–31 gauge insulin syringe. Pinch a fold of skin on the abdomen or thigh, insert the needle at a 45–90 degree angle, and inject slowly. Rotate injection sites to avoid irritation. Detailed instructions on how to inject cjc-1295 apply to the DAC version as well, though the frequency is weekly rather than daily.

Timing and Best Practices for Weekly Injections

Consistency matters more than the exact time of day when you are injecting once a week. Pick a day and time you can remember, such as Sunday evening, and stick with it.

  • Fasted state: Some protocols suggest injecting at least two hours after eating and 30 minutes before a meal to avoid blunting growth hormone release.
  • Before bed: Natural growth hormone peaks during sleep, so evening injections are common.
  • Same day each week: Because the half-life is about a week, a consistent seven-day interval keeps blood levels stable.
  • Missed dose: If you miss a scheduled injection, take it as soon as you remember unless it is almost time for the next one. Do not double the dose.

CJC-1295 DAC is not FDA-approved for human use in the United States. It is sold as a research chemical, which means it has not undergone the same safety and efficacy testing as prescription drugs. Anyone considering it should talk to a healthcare professional first.

Reported side effects from research and anecdotal reports include:

  • Injection site reactions such as redness, swelling, or pain
  • Flushing or a warm sensation
  • Headaches
  • Water retention or mild swelling in the hands and feet
  • Fatigue or lethargy
  • Numbness or tingling in the hands

These effects are often dose-dependent. Lowering the dose or switching to a split schedule may reduce them. Because CJC-1295 DAC affects growth hormone and IGF-1 levels, it may interfere with conditions like diabetes, thyroid disorders, or hormone-sensitive cancers. Medical supervision is strongly advised.

Key Takeaways

  • CJC-1295 DAC is typically injected once weekly at a dose of 1 to 2 mg.
  • The DAC technology extends the peptide's half-life to about 6 to 8 days, which is why weekly dosing works.
  • CJC-1295 without DAC must be injected once or more daily because its half-life is only about 30 minutes.
  • CJC-1295 DAC is not FDA-approved for human use and is sold for research purposes only.
  • Consult a healthcare professional before using any peptide, especially if you have a medical condition or take medication.

Frequently Asked Questions

How often do you inject CJC-1295 DAC?

Most protocols use one injection per week, typically 1 to 2 mg. Because the peptide has a half-life of about 6 to 8 days, weekly dosing is enough to maintain stable levels. Some users split the weekly dose into two injections given every three to four days.

Can you inject CJC-1295 DAC more than once a week?

You can, but it is not usually necessary. Splitting the weekly dose into two smaller shots may reduce side effects, but more frequent injections can cause overlapping activity because the peptide stays in the body for about a week. Weekly dosing is the standard.

Is CJC-1295 DAC the same as CJC-1295 without DAC?

No. CJC-1295 DAC includes the Drug Affinity Complex, which extends its half-life to 6–8 days. CJC-1295 without DAC (mod GRF 1-29) has a half-life of about 30 minutes and must be injected once or more daily. The two are not interchangeable on a weekly schedule.

Research information notice

This page provides educational research information and does not replace medical advice, diagnosis, or treatment.